Stocks and Investing Stocks and Investing
Thu, January 23, 2020
Wed, January 22, 2020

Eliana Merle Downgraded (BNTX) to Hold and Increased Target to $35 on, Jan 22nd, 2020


Published on 2024-10-26 20:32:05 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of UBS, Downgraded "BioNTech SE" (BNTX) to Hold and Increased Target from $21 to $35 on, Jan 22nd, 2020.

Eliana has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 0 agree with Eliana's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Eliana


  • Cory Kasimov of "JP Morgan" Initiated at Buy and Held Target at $23 on, Monday, November 4th, 2019
  • Daina Graybosch of "SVB Leerink" Initiated at Buy on, Monday, November 4th, 2019
  • Tazeen Ahmad of "B of A Securities" Initiated at Strong Buy and Held Target at $21 on, Monday, November 4th, 2019

Contributing Sources